Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Nicotine patch

Nicotine patch

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Nicotine patch

56 trials tracked of Nicotine patch: 25 in phase 3 or 4 and 5 with published results. The most-cited published study has 72 citations.

56Trials tracked
25Phase 3 & 4
0Recruiting
5With published results
Phase distribution
Phase 4 19 Phase 3 6 Phase 2 11 Phase 1 3 Other / NA 17
  1. Phase 4 Varenicline and Combined NRT for Smoking Cessation Completed · 72 cited
  2. Phase 4 Assessing the Integration of Tobacco Cessation Treatment Into Lung Cancer Screening (LCS) Completed · 14 cited
  3. Phase 3 Individualizing Pharmacotherapy for African American Smokers Completed · 10 cited
  4. Phase 4 Research and Innovation to Stop E-cigarette/Vaping in Young Adults Completed · 4 cited
  5. Phase 4 Improving Quitline Support Study Completed · 1 cited
  6. Phase 4 Identifying Treatments to Motivate Smokers to Quit Completed
Show 44 more trials
  1. Phase 4 Nicotine Replacement Therapy (NRT) and Bupropion Mechanisms of Effectiveness in Smokers Completed
  2. Phase 4 A Comparative Effectiveness RCT of Optimized Cessation Treatments Completed
  3. Phase 4 Nicotine Patch as an Analgesic Adjuvant After Surgery Completed
  4. Phase 4 Evaluation of the Safety Profile, Quit and Reduction Rate After Nicorette® Gum and Patch Treatment Completed
  5. Phase 4 Smoking Tobacco and Drinking Study Completed
  6. Phase 4 UW Quitting Using Intensive Treatment Study (QUITS) Completed
  7. Phase 4 Improving the Population-Wide Effectiveness of U.S. Tobacco Cessation Quitlines Completed
  8. Phase 4 Smoking Cessation Medications: Efficacy, Mechanisms and Algorithms Completed
  9. Phase 4 A Comparative Effectiveness & Long Term Health Study in Wisconsin Smokers Completed
  10. Phase 4 Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking Completed
  11. Phase 4 Effects of Smoking Environments on Brain Reactivity Completed
  12. Phase 4 Extended Treatment for Smoking Cessation Completed
  13. Phase 4 Helping Those With Mental Illness Quit Smoking Completed
  14. Phase 4 Smoking Cessation Intervention: Effectiveness in Primary Care Completed
  15. Phase 3 Smoking Termination Enhancement Project (STEP) Completed
  16. Phase 3 Topiramate Alone and in Combination With the Nicotine Patch for Smoking Cessation: A Pilot Study Completed
  17. Phase 3 Concurrent Nicotine Patch / Denicotinized Cigarette Therapy for Smoking Cessation II Completed
  18. Phase 3 PRecision Interventions for SMoking in the SCCS Completed
  19. Phase 3 Telephone Counseling and the Distribution of Nicotine Patches to Smokers Completed
  20. Phase 2 Mobile Health Technology for Personalized Tobacco Cessation Support Among Cancer Survivors in Laos Completed
  21. Phase 2 Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers Completed
  22. Phase 2 Neuroimaging Reward, Behavioral Treatment, and Smoking Cessation Completed
  23. Phase 2 Heart Rate Variability Biofeedback for Smoking Cessation Treatment Completed
  24. Phase 2 Proof-Of-Concept Investigation With a Neurosteroid Analog (Ganaxolone) as a Smoking Cessation Candidate Completed
  25. Phase 2 The Role of Nicotine Dose and Route of Delivery in Affecting Adoption of E-cigarettes and Reducing Exposure to Toxic Combustion Products Completed
  26. Phase 2 Innovative Interventions for Smoking Cessation Completed
  27. Phase 2 Combination Nicotine Patch / Lorcaserin for Smoking Cessation Completed
  28. Phase 2 Treating Smokers With Mental Illness Completed
  29. Phase 2 Project Impact 2: A Culturally Tailored Smoking Cessation Intervention for Latino Smokers Completed
  30. Phase 2 Meclizine as a Potential Smoking Cessation Treatment Completed
  31. Phase 1 Evoked Responses as Pharmacodynamic Biomarkers in Healthy and Schizophrenic Participants (MK-4334-007) Completed
  32. Phase 1 Feasibility Trial of a Tailored Smoking Cessation App for People With Serious Mental Illness Completed
  33. Phase 1 Development of a mHealth Intervention for Ambivalent Smokers Completed
  34. N/A Nicotine Withdrawal Symptoms and Smoking Relapse Completed
  35. N/A Smartphone-Delivered Attentional Bias Modification Training in Helping Patients Quit Smoking Completed
  36. N/A A Quit Smoking Study Using Smartphones Completed
  37. N/A Persistence Targeted Smoking Cessation in Serious Mental Illness (SMI) Completed
  38. N/A Smoking Cessation for Cervical Cancer Survivors Completed
  39. N/A Text Messaging for Smoking Cessation in College Health Clinics Completed
  40. N/A Supplemental Nicotine Administration for Smoking Cessation in Posttraumatic Stress Disorder (PTSD) Completed
  41. N/A Learn to Quit-HIV Pilot Study Completed
  42. N/A Cognition and Smoking Relapse (HCS) Completed
  43. N/A iQuit Mindfully: Text Messaging for Smoking Cessation Completed
  44. N/A Evaluating a Telephone-Based Smoking Cessation Program Among People in the Military (The AFIII Study) Completed

Showing the 50 most-cited and recently-updated of 56 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.